IFN-β secretion is through TLR3 but not TLR4 in human gingival epithelial cells.


Journal

Molecular immunology
ISSN: 1872-9142
Titre abrégé: Mol Immunol
Pays: England
ID NLM: 7905289

Informations de publication

Date de publication:
07 2019
Historique:
received: 06 02 2019
revised: 13 03 2019
accepted: 14 03 2019
pubmed: 7 4 2019
medline: 30 10 2019
entrez: 7 4 2019
Statut: ppublish

Résumé

The oral cavity is home for a plethora of bacteria and viruses. Epithelial barriers encounter these micro-organisms and recognize them via pathogen recognition receptors (PRRs) that instigate antibacterial and antiviral responses. We and others have shown that human gingival epithelial cells (HGECs) express PRRs to defend invading pathogens. Among these PRRs, TLR2, TLR3 and TLR4 are highly expressed in HGECs and appear to be important based on our previous findings. IFN-β is one of the major type 1 interferons induced to defend viral attack. In this report, we sought to dissect TLR3 and TLR4 mediated secretion of IFN-β in HGECs. We stimulated HGECs with ultrapure LPS (TLR4 ligand) and Poly I:C (TLR3 ligand) for 24 h and supernatant was used to determine IFN-β secretion. We show that cells treated with Poly I:C induced IFN-β secretion but not cells treated with LPS. In addition, silencing of TLR3 prior to Poly I:C stimulation significantly downregulated IFN-β secretion. On the contrary, overexpression of MD2 and TLR4 in HGECs restored IFN-β secretion. Upon further evaluation, we found that TLR3 stimulation but not TLR4 induced the phosphorylation of interferon regulatory factor 3 (IRF3), which is critical for IFN-β secretion. We conclude that IFN-β secretion is through TLR3 and not via TLR4 in HGECs.

Identifiants

pubmed: 30954023
pii: S0161-5890(19)30103-8
doi: 10.1016/j.molimm.2019.03.006
pii:
doi:

Substances chimiques

TLR3 protein, human 0
TLR4 protein, human 0
Toll-Like Receptor 3 0
Toll-Like Receptor 4 0
Interferon-beta 77238-31-4
Poly I-C O84C90HH2L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-31

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE024160
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Hellen Teixeira (H)

Department of Orthodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia PA 19004, USA.

Jiawei Zhao (J)

Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia PA 19004, USA.

Denis F Kinane (DF)

Division of Periodontology, School of Dental Medicine, University of Geneva Faculty of Medicine, Geneva, Switzerland.

Manjunatha R Benakanakere (MR)

Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia PA 19004, USA. Electronic address: bmanju@upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH